Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/30/2006 | US20060269976 Method for reducing lysozyme enzymatic activity |
11/30/2006 | US20060269975 Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis |
11/30/2006 | US20060269967 Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference |
11/30/2006 | US20060269960 Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
11/30/2006 | US20060269959 Sequences of an Ih ion channel and use thereof |
11/30/2006 | US20060269957 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
11/30/2006 | US20060269954 Self-assembling recombinant papillomavirus capsid proteins |
11/30/2006 | US20060269938 Polynucleotides encoding insect plasma membrane ca2+ ATPase and uses thereof |
11/30/2006 | US20060269936 Drug screening for agonists and antagonists to toll-like receptors using mutant TLR proteins containing deletions in extracellular leucine rich regions (LRRs); viricides, anticarcinogenic agents, antiallergens, antihistamines, bronchodilator agents; chronic obstructive pulmonary disease, asthma |
11/30/2006 | US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins |
11/30/2006 | US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
11/30/2006 | US20060269566 Polypeptide comprising extracellular domain which induces T-cell proliferation response; gene therapy; vaccines; antiproliferative/antitumor agents; cytotoxic T-lymphocyte (CTLA) |
11/30/2006 | US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis |
11/30/2006 | US20060269559 Novel human histone deacetylases |
11/30/2006 | US20060269557 Humanized anti-prostate stem cell antigen monoclonal antibody |
11/30/2006 | US20060269555 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
11/30/2006 | US20060269554 DR5 antibodies and uses thereof |
11/30/2006 | US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies |
11/30/2006 | US20060269550 Anti-ghrelin fab antibodies |
11/30/2006 | US20060269547 Humanized anti-CD3 specific antibodies |
11/30/2006 | US20060269546 Androgen-regulated PMEPA1 gene and polypeptides |
11/30/2006 | US20060269545 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
11/30/2006 | US20060269544 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
11/30/2006 | US20060269541 S.agalactiae antigens I + II |
11/30/2006 | US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents |
11/30/2006 | US20060269538 Serine proteases with altered sensitivity to activity-modulating substances |
11/30/2006 | US20060269532 Compositions and methods for the therapy and diagnosis of prostate cancer |
11/30/2006 | US20060269528 Production detection and use of transformant cells |
11/30/2006 | US20060269515 Interleukin-2 muteins |
11/30/2006 | CA2609593A1 Anti-cd16 binding molecules |
11/30/2006 | CA2609164A1 Gene of transporter selective to mugineic acid-iron complex |
11/30/2006 | CA2608579A1 Scalable fermentation process |
11/30/2006 | CA2607739A1 Compositions and methods for treating malaria with cupredoxin and cytochrome |
11/29/2006 | EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides |
11/29/2006 | EP1725659A2 Natural igm antibodies and inhibitors thereof |
11/29/2006 | EP1725587A2 Compositions and methods for detection of single molecules |
11/29/2006 | EP1725251A2 Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
11/29/2006 | EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides |
11/29/2006 | EP1423708B1 Compositions and methods for aa4rp assay |
11/29/2006 | EP1353953B1 Mu-1, member of the cytokine receptor family |
11/29/2006 | EP1259223A4 Protein matrix materials, devices and methods of making and using thereof |
11/29/2006 | EP1248804B1 Recombinant antibodies to human interleukin-1 beta |
11/29/2006 | EP1221489B1 Regulatory sequences functioning in filamentous fungi |
11/29/2006 | EP1220911B1 P-glycoproteins and uses thereof |
11/29/2006 | EP1196598B1 Dsp-3 dual-specificity phosphatase |
11/29/2006 | EP1141026B1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
11/29/2006 | EP1117692B1 Tie2 agonist antibodies |
11/29/2006 | EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide |
11/29/2006 | EP0943690B1 Method for refolding human activin a |
11/29/2006 | EP0931151B1 Thermostable nucleic acid polymerase from thermococcus gorgonarius |
11/29/2006 | EP0837936B1 New immunoregulatory protein lst-1 |
11/29/2006 | EP0821695B1 Antibody purification by low-ph hydrophobic interaction chromatography |
11/29/2006 | EP0785716B1 Cytokine designated lerk-6 |
11/29/2006 | EP0556292B2 Hepatitis c virus asialoglycoproteins |
11/29/2006 | CN1871359A Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
11/29/2006 | CN1871351A Novel fungal proteins and nucleic acids encoding same |
11/29/2006 | CN1871255A Novel secretory protein and production process and use thereof |
11/29/2006 | CN1871252A Method for the production of fusion proteins in transgenic mammal milk |
11/29/2006 | CN1869228A Production method of recombination human interferon gamma |
11/29/2006 | CN1869221A Method of producing recombination human monocyte/neutral granular cell elastic pankrin inhibiting protein (hNEI) |
11/29/2006 | CN1869217A Method for producing transgene protein medicine of mammary gland expression using gland virus as carrier mammary |
11/29/2006 | CN1869216A Expression method of recombination human bone formation protein-2 |
11/29/2006 | CN1869214A Method for high efficiency expressing destination protein |
11/29/2006 | CN1869070A High efficiency low poison immune toxin and its preparation method and application |
11/29/2006 | CN1869069A Recombination enterovirus 71 type neutralization antibudy and its use |
11/29/2006 | CN1286976C Interferon-alpha/beta binding protein, its preparation and use |
11/29/2006 | CN1286975C High affinity immunoglobulin for human antigen and heterologous tumour for manufacturing thereof |
11/29/2006 | CN1286974C Mutant of recombined glucokinase for anti blood platelet collecting and low immunogenic |
11/28/2006 | US7141664 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids |
11/28/2006 | US7141663 Nucleic acids, expression vectors, host cells, and improved exogenous gene expression in microorganisms; amino acid biosynthesis of fine chemicals |
11/28/2006 | US7141662 Diagnosis using antibodies; culture product |
11/28/2006 | US7141656 In situ screening, isolation of peptides; major histocompability complex |
11/28/2006 | US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders |
11/28/2006 | US7141652 Antibodies to PRO1561 polypeptide |
11/28/2006 | US7141651 Multiple cytokine protein complexes |
11/28/2006 | US7141547 Albumin fusion proteins comprising GLP-1 polypeptides |
11/28/2006 | US7141435 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP |
11/28/2006 | US7141420 Retina specific; for inhibition of macular degeneration |
11/28/2006 | US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
11/28/2006 | US7141410 Methods and materials for the production of organic products in cells of Candida species |
11/28/2006 | US7141409 Hyaluronan synthase gene and uses thereof |
11/28/2006 | US7141404 Candida kefyr cytosine deaminase |
11/28/2006 | US7141395 Biological control of crown gall disease |
11/28/2006 | US7141394 Using isobutyl-C-galactoside (IBCG) as a functional replacement of isopropylthiogalactoside (IPTG) in inducing expression of proteins under control of the lactose operon promoter; functions as mimic or substitute for galactose |
11/28/2006 | US7141393 Interleukin-18-receptor proteins |
11/28/2006 | US7141389 Chromosome DNA coding for human hepatocyte growth factor |
11/28/2006 | US7141388 Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum |
11/28/2006 | US7141383 EDG8 receptor, its preparation and use |
11/28/2006 | US7141381 Human leucine-rich repeat-containing proteins specifically expressed in the nervous system |
11/28/2006 | US7141376 Carrier tests for polycystic kidney disease in the cat |
11/28/2006 | US7141366 Surface display of selenocysteine-containing peptides |
11/28/2006 | US7141365 Methods for diagnosing a mucin production associated disease condition |
11/28/2006 | US7141363 Purposeful movement of human migratory cells away from an agent source |
11/28/2006 | US7141244 Helicobacter pylori proteins useful for vaccines and diagnostics |
11/28/2006 | US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof |
11/28/2006 | CA2294355C Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
11/28/2006 | CA2226968C Novel monoclonal antibody, and immunological assay of e-d-dimer and e-dd/e complex |
11/28/2006 | CA2208095C Generation of human insulin |
11/28/2006 | CA2114636C Recombinant plant viral nucleic acids |
11/28/2006 | CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism |